Quest Diagnostics Partners CDC To Offer Free COVID-19 Laboratory Testing To Underserved Communities

(RTTNews) - Quest Diagnostics (DGX), the provider of diagnostic information services, announced Thursday it is partnering the Centers for Disease Control and Prevention's (CDC) Increasing Community Access to Testing (ICATT) for COVID-19 program. The CDC chose Quest following a competitive bid. However, financial terms were not disclosed.

The program is designed to support free COVID-19 laboratory testing for patients in U.S. communities that have been disproportionately affected by the pandemic.

This will provide qualified uninsured individuals access to Quest Diagnostics' COVID-19 molecular diagnostic testing at approximately 1,200 of its 2,100 patient service centers.

The CDC is harnessing the power of public-private collaboration to broaden access to critical COVID-19 laboratory testing for those most in need.

To qualify, individuals must complete a brief online screening questionnaire via QuestDirect, the consumer-initiated testing service from Quest Diagnostics. Both uninsured and insured individuals two years of age and older are eligible.

For More Such Health News, visit rttnews.com